Iradimed Corporation (IRMD) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Iradimed Corporation  (NASDAQ: IRMD)


Iradimed's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Iradimed's ROI in the third quarter of 2026?
Iradimed Corporation achieved a return on average invested assets (ROI) of 22.98 % in its third quarter of 2026, this is above IRMD's average return on investment of 14.67%.
Iradimed Corporation invested over the 12 months ending in its third quarter of 2026 $104 million

ROI has improved compared to 22.57% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 44 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 241, from total ROI ranking in the second quarter of 2026 at 247.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 9.09 % 11.37 % 13.84 % 15.5 % 19.2 %
Y / Y Net Income Change TTM 13.21 % 11.6 % 58.63 % 120.47 % 319.54 %
Investment (TTM) in Millions 111 106 102 99 102
Return On Investment (TTM) 22.98 % 22.57 % 23.59 % 22.97 % 22.15 %
IRMD's Overall Ranking # 241 # 247 # 163 # 191 #
Seq. Investment Change TTM 2.16 % 2.04 % 2.3 % 2.3 % 4.29 %
Seq. Net Income Change TTM 4.03 % -2.35 % 5.03 % 6.11 % 2.55 %
Net Income (TTM) in Millions 24 23 24 22 21

IRMD Company Profile >> Back to IRMD Roi Comparisons >> See Annual IRMD Return On Investment



Return On Investment IRMD's Ranking
Within: No.
Industry # 8
Sector # 45
Overall # 241

Return On Investment Statistics
High Average Low
29.28 %
14.67 %
-22.2 %
(Jun 30 2016)   (Mar 31 2015)







Financial Statements
Iradimed's III. Quarter Investments $ 111 Millions IRMD's Balance sheet
Iradimed's III. Quarter Income $ 7 Millions Quarterly IRMD's Income Statement
IRMD's Income by Division See IRMD's Income by Division


IRMD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 99 90 72 77 76
Y / Y Investment Growth 9.78 % 24.89 % -6.55 % 1.19 % 14.98 %
Net Income in Millions 22 19 17 13 9
Y / Y Net Income Growth 16.88 % 11.87 % 34.02 % 37.56 % 581.19 %
Annual Return On Investment 22.8 % 21.42 % 23.91 % 16.67 % 12.26 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 22.8 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
IRMD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for IRMD's Competitors
Subscribers only: Roi for Iradimed's Suppliers
Subscribers only: Return On Investment for IRMD's Customers

Other Ratios
IRMD's Roa IRMD's Inventory Turnover Ratio IRMD's Growth Rates IRMD's Dividend Statistics
IRMD's Profitability Ratios IRMD's Asset Turnover Ratio IRMD's Dividend Growth
IRMD's Roe IRMD's Valuation Ratios IRMD's Financial Strength Ratios IRMD's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Alnylam Pharmaceuticals Inc   63.14 %
Idexx Laboratories Inc  52.51 %
Aurinia Pharmaceuticals Inc   45.04 %
Nurix Therapeutics Inc   44.12 %
Medpace Holdings Inc   41.14 %
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Protalix Biotherapeutics inc   26.06 %
Standard Biotools Inc   23.91 %
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %

Date modified: 2026-10-31T09:56:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.